Julie E Lang

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. ncbi Radiation-induced sarcoma of the breast: a systematic review
    Grishma R Sheth
    Department of Surgery, Division of Surgical Oncology, University of Arizona, 1501 N Campbell Avenue, Room 4327, P O Box 245131, Tucson, Arizona 85724, USA
    Oncologist 17:405-18. 2012
  2. ncbi A comparison of RNA amplification techniques at sub-nanogram input concentration
    Julie E Lang
    Department of Surgery, UCSF Comprehensive Cancer Center, 1500 Divisadero Street, San Francisco, CA 94143, USA
    BMC Genomics 10:326. 2009
  3. ncbi Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Julie E Lang
    The University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Unit 444, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Expert Rev Anticancer Ther 7:1463-72. 2007
  4. ncbi Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation
    Julie E Lang
    Department of Surgery, University of California San Francisco, San Francisco, CA 94114, USA
    J Am Coll Surg 199:856-62. 2004
  5. ncbi Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer?
    Liang Chih Liu
    Department of Surgery and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA
    J Am Coll Surg 207:853-8. 2008
  6. ncbi Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer
    Julie E Lang
    Department of Surgery and UCSF Comprehensive Cancer Center, UCSF, San Francisco, CA 94143 1674, USA
    Breast J 15:242-6. 2009

Collaborators

Detail Information

Publications6

  1. ncbi Radiation-induced sarcoma of the breast: a systematic review
    Grishma R Sheth
    Department of Surgery, Division of Surgical Oncology, University of Arizona, 1501 N Campbell Avenue, Room 4327, P O Box 245131, Tucson, Arizona 85724, USA
    Oncologist 17:405-18. 2012
    ..Breast cancer survivors treated with radiotherapy constitute a large fraction of RIS patients. To evaluate evidenced-based practices for RIS treatment, we performed a systematic review of the published English-language literature...
  2. ncbi A comparison of RNA amplification techniques at sub-nanogram input concentration
    Julie E Lang
    Department of Surgery, UCSF Comprehensive Cancer Center, 1500 Divisadero Street, San Francisco, CA 94143, USA
    BMC Genomics 10:326. 2009
    ..Microarray data from each amplification method were validated against quantitative real-time PCR (QPCR) for 37 genes...
  3. ncbi Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Julie E Lang
    The University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Unit 444, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Expert Rev Anticancer Ther 7:1463-72. 2007
    ..The purpose of this report is to review the data regarding CTCs and DTCs in patients with operable breast cancer...
  4. ncbi Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation
    Julie E Lang
    Department of Surgery, University of California San Francisco, San Francisco, CA 94114, USA
    J Am Coll Surg 199:856-62. 2004
    ....
  5. ncbi Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer?
    Liang Chih Liu
    Department of Surgery and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA
    J Am Coll Surg 207:853-8. 2008
    ..We hypothesized that the node with the highest radioactivity would have the strongest probability of being a positive SLN, and we sought to determine the lowest radioactive count of a node harboring cancer...
  6. ncbi Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer
    Julie E Lang
    Department of Surgery and UCSF Comprehensive Cancer Center, UCSF, San Francisco, CA 94143 1674, USA
    Breast J 15:242-6. 2009
    ..57), or overall survival (p = 0.70). Positive non-SLNs removed during SSL are not a significant risk factor for additional positive nodes on completion axillary nodal dissection (CALND) or for worse survival than positive SLNs...